News
Novartis Announces $250M Funding In R&D For NTDs, Malaria
Novartis has committed to investing $250 million in research and development over the next five years in an effort to find a cure for...
News
GSK Pledges £1 Billion R&D Commitment For The Poor Nations
In order to speed up research and development (R&D) for communicable diseases that disproportionately hurt lower-income nations, GSK plc announced a commitment of £1 billion...
News
BioNTech And Regulator Differ On COVID Jab Approval- WAS
According to a story in the Welt Am Sonntag (WAS) newspaper, the launch of the vaccine developed by German pharmaceutical company BioNTech for the Omicron...
News
The Future of Male Contraception
We have come a long way when it comes to female contraception. From caps and diaphragms to implants and injections, the number of options...
News
Alexion Irish Factory Gets A $68.7M Upgrade From AstraZeneca
The $39 billion acquisition of Alexion by AstraZeneca was accomplished less than a year ago. However, the main business is investing immediately in its...
Articles
Selecting an optimized stability plan for your injectable drug product
No matter the indication, molecule, or therapeutic area, every drug developer working on a parenteral medication needs to answer the same essential question: what’s...
Press Releases
ChargePoint Technology’s new facility expands into Europe
Powder containment and aseptic transfer valve market-leader, ChargePoint Technology, has opened a new facility just outside of Munich, Germany as it continues its growth...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read